Phase 2 Completed N=45 Randomized Triple-blind

Study of Vitamin D and Effect on Heart Disease and Insulin Resistance

HIV · Vitamin D deficiency

Source: ClinicalTrials.gov NCT01093417 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2012

Primary outcomePrimary: Change in Endothelial Function — 0.29; 0.55 percent change in endothelial function

Summary

The purpose of this study is to evaluate how Vitamin D affects endothelial function, inflammation, lipids, insulin resistance, vitamin D levels, and parathyroid hormone (PTH).

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Endothelial Function	0.29; 0.55	—
SECONDARY Change in Serum 25-hydroxyvitamin D Concentration in Both Groups	-1.8; 5.0	—

Eligibility Criteria

Inclusion Criteria

HIV infected
HIV-RNA 2.5 within 6 months prior to study entry

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01093417). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.